Endo International Plc., Johnson & Johnson and other drugmakers who confront litigation during the opioid emergency are researching a means to settle the cases by participating in Purdue Pharma LP’s insolvency, the Wall Street Journal reported, citing internal documents and a individual familiar with the matter.